In this episode of the Health Tech World Podcast, host Gordon speaks with Kathleen van Vlierberghe, Vice President for EMEA Peripheral Intervention at Boston Scientific, about how kidney cancer care in the UK is evolving.
Together, they explore the impact of the first-ever NICE kidney cancer guidelines, why minimally invasive treatments like cryoablation remain underused and how better awareness, earlier diagnosis and more equitable access to treatment could transform outcomes.
Listen below on YouTube or find on your podcast platform of choice:
